Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is experiencing a recovery in the European electronic vaporization market, and the HNB (Heat-not-Burn) segment is expected to release profit elasticity [8] - The company's revenue for the first half of 2025 reached 6.013 billion yuan, a year-on-year increase of 18.3%, aligning with forecast values and exceeding initial high single-digit expectations [8] - The HNB market is in a rapid growth phase, with the company collaborating with British American Tobacco on new products, indicating potential for future profit contributions [8] Financial Summary - Total revenue projections for the company are as follows: - 2023A: 11.177 billion yuan - 2024A: 11.799 billion yuan - 2025E: 13.722 billion yuan - 2026E: 16.166 billion yuan - 2027E: 18.395 billion yuan - Year-on-year growth rates are projected at (8.06)%, 5.56%, 16.30%, 17.81%, and 13.79% respectively [1] - Net profit attributable to the parent company is forecasted as: - 2023A: 1.645 billion yuan - 2024A: 1.303 billion yuan - 2025E: 1.329 billion yuan - 2026E: 2.217 billion yuan - 2027E: 2.891 billion yuan - Year-on-year growth rates are projected at (34.47)%, (20.78)%, 1.96%, 66.84%, and 30.40% respectively [1] - The latest diluted EPS (Earnings Per Share) is projected as follows: - 2023A: 0.27 yuan - 2024A: 0.21 yuan - 2025E: 0.21 yuan - 2026E: 0.36 yuan - 2027E: 0.47 yuan [1] - The P/E (Price-to-Earnings) ratios at current price and latest diluted EPS are: - 2023A: 80.56 - 2024A: 101.69 - 2025E: 99.73 - 2026E: 59.78 - 2027E: 45.84 [1]

Core Viewpoint - The company reported strong revenue growth in the first half of the year, driven by regulatory enforcement in the US and Europe, while net profit declined due to increased non-cash share-based payments and rising operational costs [1][2][3] Financial Performance - The company achieved revenue of 6.013 billion yuan, a year-on-year increase of 18.3%, while net profit was 492 million yuan, down 28.0% year-on-year [1] - Adjusted net profit was 737 million yuan, a slight decrease of 2.1% year-on-year, aligning with previous forecasts [1] - The gross profit margin for the first half was 37.3%, a decrease of 0.5 percentage points year-on-year [3] Business Segments - The To B business segment generated revenue of 4.939 billion yuan, up 19.5% year-on-year, with significant growth in Europe and other markets [2] - The To C business segment reported revenue of 1.274 billion yuan, a year-on-year increase of 14.1%, with notable performance from the "Lan Zhi" brand in China [2] - The HNB (Heat-not-Burn) business is progressing as planned, with product launches in Serbia and Sendai, Japan, expected to expand further [3] Cost and Expenses - The increase in share-based payments contributed to a rise in management expense ratios, while R&D expense ratios decreased [3] - Distribution and sales expenses rose due to increased marketing efforts for the company's own brands and global expansion [3] Future Outlook - The company anticipates continued recovery in its core vaporization business, supported by improving regulatory frameworks in the US and Europe [1][2] - The introduction of new HNB products is expected to open a second growth curve for the company [3] Profit Forecast and Valuation - Profit forecasts have been adjusted downward due to the impact of share-based payments, with expected net profits for 2025-2027 at 1.007 billion, 1.830 billion, and 2.559 billion yuan respectively [3] - The target price for the company's stock is set at 27.00 HKD, based on a 71 times PE ratio for 2026 [3]

Core Viewpoint - The company reported its 2025 first-half results, showing revenue growth driven by effective enforcement actions against non-compliant products and the rapid launch of innovative compliant products to meet market demand [1] Group 1: Financial Performance - In H1 2025, the company achieved revenue of 6.013 billion yuan, a year-on-year increase of 18.3%, while net profit was 492 million yuan, a decrease of 28.0% [1] - Adjusted net profit was 737 million yuan, down 2.1% year-on-year [1] - The gross margin for H1 2025 was 37.3%, a decrease of 0.5 percentage points year-on-year [2] Group 2: Business Segments - The self-owned brand business generated revenue of 1.274 billion yuan, up 14.1% year-on-year, with significant growth in Europe and other regions [1] - Revenue from the HNB (Heated Not Burned) business is expected to grow significantly, with the global market projected to reach approximately 66.86 billion USD by 2029, growing at a CAGR of about 10.1% from 2024 to 2029 [2] Group 3: Strategic Initiatives - The company is increasing marketing investments and enhancing employee incentives to solidify long-term competitive advantages [2] - The company is focusing on supporting strategic clients in launching high-end HNB product series in key markets, with positive early consumer feedback [2] Group 4: Future Outlook - The company expects revenue growth for 2025-2027 to be 13.45 billion, 15.49 billion, and 17.66 billion yuan respectively, with year-on-year growth rates of 14%, 15%, and 14% [3] - The company anticipates a significant increase in net profit in 2026 and 2027, with projections of 1.812 billion and 2.595 billion yuan respectively [3]

Core Viewpoint - Smoore International (06969) reported a strong performance in its interim results, with revenue growth driven by effective enforcement actions against non-compliant products and the company's ability to quickly launch innovative compliant products to meet market demand [1] Financial Performance - The company achieved a revenue of RMB 6.013 billion in the first half of the year, representing an increase of 18.3% year-on-year [1] - Adjusted profit for the period was RMB 737 million, a decrease of 2.1% year-on-year, while net profit was RMB 492 million, down 27.96% year-on-year [1] Business Segments - The ToB (business-to-business) segment generated approximately RMB 4.739 billion in revenue, reflecting a year-on-year growth of about 19.5% [1] - The proprietary brand electronic vaporization business achieved revenue of approximately RMB 1.274 billion, with a year-on-year increase of about 14.1%, supported by the strong performance of the leading brand VAPORESSO [1]

Core Insights - Smoore International (06969) experienced a stock price increase of over 8% post-earnings report, currently trading at HKD 23.12 with a transaction volume of HKD 297 million [1] Financial Performance - For the first half of the year, the company reported revenue of RMB 6.013 billion, representing a year-on-year increase of 18.3% [1] - Adjusted profit for the period was RMB 737 million, a decrease of 2.1% year-on-year, while net profit fell to RMB 492 million, down 27.96% year-on-year [1] Market Dynamics - Revenue growth was primarily driven by effective enforcement actions against non-compliant products in major global markets, alongside the company's agile ability to launch innovative compliant products to meet market demand [1] - The company's ToB (business-to-business) segment generated approximately RMB 4.739 billion in revenue, reflecting a year-on-year growth of about 19.5% [1] Brand Performance - The self-branded electronic vaporization business achieved revenue of approximately RMB 1.274 billion, marking a year-on-year increase of 14.1%, supported by the strong performance of the industry-leading brand VAPORESSO [1]

Core Insights - The company achieved revenue of RMB 6.013 billion for the six months ending June 30, 2025, representing a year-on-year growth of 18.3% [1] - Adjusted net profit was RMB 737 million, showing a decrease of 2.1% compared to the previous year [1] Revenue Breakdown - The ToB (Business-to-Business) segment generated revenue of RMB 4.739 billion, reflecting a year-on-year increase of 19.5% [1] - The proprietary brand business reported revenue of RMB 1.274 billion, which is a year-on-year growth of 14.1%, with strong performance from the VAPORESSO brand [1] Expense Analysis - Sales and distribution expenses increased by 31.2% year-on-year, amounting to approximately RMB 491 million [1] - Research and development expenses were RMB 723 million, showing a decline of 4.9% year-on-year, as the company prioritized key R&D projects while reducing investment in electronic vaporization products [1]

Core Viewpoint - Smoore International (06969) reported a revenue of RMB 6.013 billion for the six months ending June 30, 2025, representing an 18.3% year-on-year increase, driven by effective enforcement against non-compliant products and the company's ability to quickly launch innovative compliant products to meet market demand [1] Group 1: Financial Performance - The adjusted profit for the period was RMB 737 million, a decrease of 2.1% year-on-year [1] - The net profit for the period was RMB 492 million, down 27.96% year-on-year [1] - Basic earnings per share were 8.08 cents [1] Group 2: Business Growth Drivers - The company's ToB (business-to-business) segment generated revenue of approximately RMB 4.739 billion, an increase of about 19.5% year-on-year [1] - The proprietary brand electronic vaporization business achieved revenue of approximately RMB 1.274 billion, a year-on-year increase of about 14.1%, supported by strong performance from the leading brand VAPORESSO [1] Group 3: Market Strategy and R&D - The company emphasizes close interaction with end-users to understand consumer preferences and enhance product placement, which drives sales growth [2] - Sales and distribution expenses were approximately RMB 491 million, an increase of about 31.2% year-on-year [2] - The company continues to invest in R&D to maintain its technological leadership, with R&D expenses amounting to approximately RMB 723 million, a decrease of about 4.9% year-on-year [2]

Group 1 - The company reported a revenue of RMB 6.013 billion for the six months ending June 30, 2025, representing an 18.3% year-on-year increase [1] - Adjusted profit for the period was RMB 737 million, a decrease of 2.1% year-on-year, while net profit was RMB 492 million, down 27.96% year-on-year [1] - The growth in revenue was primarily driven by effective enforcement actions against non-compliant products in major global markets and the company's ability to quickly launch innovative compliant products [1] Group 2 - The company's ToB (business-to-business) segment achieved revenue of approximately RMB 4.739 billion, reflecting a year-on-year increase of about 19.5% [1] - The proprietary brand electronic vaporization business generated revenue of approximately RMB 1.274 billion, with a year-on-year growth of about 14.1%, supported by strong performance from the leading brand VAPORESSO [1] - The company emphasized close interaction with end-users to understand consumer preferences and enhance product placement, which contributed to sales growth [2] Group 3 - The company invested in local operations and expanded retail channel coverage in major global markets, resulting in a sales and distribution expense of approximately RMB 491 million, an increase of about 31.2% year-on-year [2] - Continuous investment in research and development (R&D) is a key competitive advantage for the company, with R&D expenditure amounting to approximately RMB 723 million, a decrease of about 4.9% year-on-year [2] - The company focused on strategic R&D projects while reducing investment in electronic vaporization products to enhance R&D efficiency and optimize resource allocation [2]

Core Viewpoint - Smoore International (06969.HK) reported a revenue of approximately RMB 6.013 billion for the first half of 2025, representing an increase of about 18.3% compared to the same period last year [1] Financial Performance - The company's profit for the review period was approximately RMB 492 million; adjusted profit, excluding stock-based non-cash payment expenses, was about RMB 737 million [1] - Earnings per share were RMB 8.08 [1] Business Segments - The growth in sales performance was primarily driven by effective enforcement actions against non-compliant products in major global markets and the company's agile ability to launch innovative compliant products to meet market demand [1] - The ToB (business-to-business) segment recorded revenue of approximately RMB 4.739 billion, a year-on-year increase of about 19.5% [1] - The proprietary brand electronic vaporization business achieved revenue of approximately RMB 1.274 billion, reflecting a year-on-year growth of about 14.1%, supported by the strong performance of the leading brand VAPORESSO and expanded channel coverage [1]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 25.00, up from the previous target of HKD 16.25 [6][4]. Core Insights - The company is expected to see a revenue increase of 18% year-on-year for the first half of 2025, with projected revenue of HKD 60.13 billion. However, net profit is forecasted to decline by 21% to 35% year-on-year, primarily due to increased non-cash share payments and rising operational costs associated with expanding its proprietary brand business [1][4]. - The regulatory environment in the US and Europe is tightening, which is anticipated to drive demand for compliant products, positively impacting the company's core vaporization business [2][4]. - The new HNB product, Glo Hilo, has shown promising performance in the Japanese market, indicating significant growth potential for the company as it expands its product offerings [3][4]. Summary by Sections Revenue and Profit Forecast - The company forecasts a net profit of HKD 13.23 billion, HKD 21.40 billion, and HKD 27.62 billion for the years 2025 to 2027, respectively, with corresponding EPS of HKD 0.21, HKD 0.35, and HKD 0.45 [4][10]. Market and Regulatory Environment - The report highlights that the enforcement of regulations by the FDA in the US and similar measures in Europe are expected to restore sales of compliant vapor products, benefiting the company's market position [2][4]. Product Development and Innovation - The Glo Hilo product, launched in Japan, features enhanced heating efficiency and a variety of flavor options, which are expected to validate the product's market potential and drive future growth [3][4]. Valuation Metrics - The report assigns a PE ratio of 65 for 2026, reflecting the company's strong growth prospects and competitive advantages in the HNB market, leading to a target price increase [4][10].